{
    "Table 1": [
        {
            "VMD": [
                {
                    "parent": "Disease Description",
                    "children": [
                        {"parent": "Tumor Characteristics", "children": []},
                        {"parent": "Location and Behavior", "children": []}
                    ]
                },
                {
                    "parent": "Patient History",
                    "children": [
                        {"parent": "Previous Medical Procedures", "children": []},
                        {"parent": "Previous Treatments and Recurrence", "children": []}
                    ]
                },
                {
                    "parent": "Diagnostic Approach",
                    "children": [
                        {"parent": "Imaging and Tests", "children": []},
                        {"parent": "Multidisciplinary Discussions", "children": []}
                    ]
                },
                {
                    "parent": "Surgical Management",
                    "children": [
                        {"parent": "Procedure Description", "children": []},
                        {"parent": "Materials and Techniques", "children": []}
                    ]
                },
                {
                    "parent": "Postoperative Outcomes",
                    "children": [
                        {"parent": "Immediate Outcomes", "children": []},
                        {"parent": "Long-term Follow-up", "children": []}
                    ]
                },
                {
                    "parent": "Ethical Considerations",
                    "children": [
                        {"parent": "Informed Consent and Protocol", "children": []},
                        {"parent": "Financial Disclosure", "children": []}
                    ]
                }
            ]
        },
        {
            "Data": [
                ["Desmoid-type fibromatosis, aggressive, benign, monoclonal fibroblast proliferation. Size: 18 × 10 × 6.4 cm."],
                ["Located in the left anterolateral abdominal wall, locally aggressive, high risk of local recurrence."],
                ["Previous exeresis of abdominal neoplasm, appendectomy, two cesarean sections, and a voluntary pregnancy termination."],
                ["Initially treated with a small prosthetic mesh; recurrence in 2014 treated with tamoxifen and chemotherapy."],
                ["MRI used for tumor staging showing significant progression."],
                ["Case discussed in Multidisciplinary Sarcoma Meeting leading to decision for surgical treatment."],
                ["Large excision of tumor and affected muscles with reconstruction using a biological matrix (Egis®)."],
                ["Use of non-cross-linked porcine dermal matrix Egis®, hydrated and sutured to the fascia and abdominal wall muscles."],
                ["Uncomplicated postoperative course, discharged on the 8th day."],
                ["No evidence of recurrence or incisional hernia at 12 months, successful integration of the biological matrix with tissues."],
                ["Informed consent obtained, study protocol approved complying with Helsinki guidelines."],
                ["No funding for paper preparation, no conflicts of interest declared."]
            ]
        }
    ],
    "Table 2": [
            {
                "VMD": [
                    {
                        "parent": "Case Overview",
                        "children": []
                    },
                    {
                        "parent": "Patient History",
                        "children": [
                            {"parent": "Past Surgical History", "children": []},
                            {"parent": "Other Relevant History", "children": []}
                        ]
                    },
                    {
                        "parent": "Tumor Characteristics and Location",
                        "children": [
                            {"parent": "Tumor Type", "children": []},
                            {"parent": "Location", "children": []},
                            {"parent": "Size and Progression", "children": []}
                        ]
                    },
                    {
                        "parent": "Treatment Strategy",
                        "children": [
                            {"parent": "Initial Treatments", "children": []},
                            {"parent": "Surgical Decision", "children": []}
                        ]
                    },
                    {
                        "parent": "Surgical Details",
                        "children": [
                            {"parent": "Resection Details", "children": []},
                            {"parent": "Reconstruction", "children": []}
                        ]
                    },
                    {
                        "parent": "Outcome and Follow-up",
                        "children": [
                            {"parent": "Immediate Postoperative Course", "children": []},
                            {"parent": "Long-term Follow-up", "children": []}
                        ]
                    }
                ]
            },
            {
                "Data": [
                    ["Desmoid Fibromatosis of the Abdominal Wall, surgical resection and reconstruction with biological matrix Egis®"],
                    ["Previous exeresis of a neoplasm in the epigastric region, reinforced with prosthetic mesh"],
                    ["Appendectomy, two cesarean births, voluntary pregnancy termination"],
                    ["Desmoid-type fibromatosis"],
                    ["Left anterolateral abdominal wall"],
                    ["Initial size not specified; Recurrent size 18 × 10 × 6.4 cm; Aggressive growth noted in MRI"],
                    ["Tamoxifen therapy for 1 year, followed by 3 months of neoadjuvant chemotherapy"],
                    ["Decision for surgical resection made after multidisciplinary discussions"],
                    ["Large excision of the tumor with negative margins; involved the abdominal rectus muscle and parts of oblique and transverse muscles"],
                    ["Utilized Egis® non-cross-linked porcine dermal matrix, hydrated and sutured to the fascia and abdominal wall muscles"],
                    ["Uncomplicated, discharged on the 8th postoperative day"],
                    ["No recurrence of the tumor or incisional hernia at 12 months post-operation; successful integration of the biological matrix"]
                ]
            }
        ],
        "Table 3": [
                {
                    "VMD": [
                        {
                            "parent": "Disease Description",
                            "children": [
                                {"parent": "Nature and Epidemiology", "children": []},
                                {"parent": "Risk Factors and Demographics", "children": []}
                            ]
                        },
                        {
                            "parent": "Patient Case History",
                            "children": [
                                {"parent": "Initial Condition and Treatments", "children": []},
                                {"parent": "Recurrence and Further Management", "children": []}
                            ]
                        },
                        {
                            "parent": "Surgical Procedure",
                            "children": [
                                {"parent": "Procedure Description", "children": []},
                                {"parent": "Technology and Materials Used", "children": []}
                            ]
                        },
                        {
                            "parent": "Postoperative Outcome",
                            "children": [
                                {"parent": "Immediate Results", "children": []},
                                {"parent": "Follow-Up Results", "children": []}
                            ]
                        },
                        {
                            "parent": "Discussion and Implications",
                            "children": [
                                {"parent": "Surgical Choices and Justifications", "children": []},
                                {"parent": "Long-Term Outlook and Recommendations", "children": []}
                            ]
                        }
                    ]
                },
                {
                    "Data": [
                        ["Desmoid tumor (DT) is a benign monoclonal fibroblast proliferation, rare with 2-5 cases per million annually in Europe. It's locally aggressive and recurrent, with high risk of local recurrence despite surgical resection."],
                        ["Risk factors include surgical interventions, pregnancy, and hormonal treatment. The median diagnosis age is 35, frequently affecting women, particularly on the abdominal wall."],
                        ["A 37-year-old woman with a history of DT, previously excised and reinforced with mesh. Later treatments included tamoxifen and chemotherapy due to disease progression."],
                        ["MRI in 2015 showed progression; surgical resection was decided upon by a multidisciplinary team."],
                        ["The tumor and affected muscles were excised en bloc, followed by reconstruction using a biological matrix (Egis®), secured to the fascia and abdominal wall muscles."],
                        ["Egis® (Decomed), a not cross-linked porcine dermal matrix, chosen for favorable properties such as resistance to infection and compatibility with patient tissue."],
                        ["Uncomplicated recovery, patient discharged on the 8th day."],
                        ["No recurrence or hernia noted at 12 months, MRI confirmed successful integration of the biological matrix with surrounding tissues."],
                        ["Wide excision necessary for local control; biological matrices preferred over synthetic meshes due to lower risk of complications like adhesion and infection."],
                        ["Emphasizes the necessity of wide disease-free margins and potential benefits of ADMs over synthetic meshes in abdominal reconstructions."]
                    ]
                }
            ]
        }

